12th Dec 2007 09:00
Smith & Nephew Plc12 December 2007 FOR IMMEDIATE RELEASE Smith & Nephew announces international launch of new ALLEVYN* Gentle and ALLEVYN* Gentle Border wound dressings Addition of new products to the ALLEVYN* range provides a complete customersolution in advanced wound care management Hull, (U.K), December 12 2007 The Advanced Wound Management business unit of Smith & Nephew (LSE: SN; NYSE:SNN) announced today that it is launching two new ALLEVYN products to enhanceits existing range of progressive wound care products. ALLEVYN Gentle and ALLEVYN Gentle Border combine the superior moisture handlingof the ALLEVYN range with the unique benefits of silicone gel and soft-geladhesives, helping to deliver the optimal environment for the promotion offaster wound healing, whilst simultaneously maximising comfort and minimisingpain for the patient. Commenting on the launch, Joe Woody, President, Smith & Nephew Advanced WoundManagement, said: "Following the successful launch of ALLEVYN Ag in September,the addition of the ALLEVYN Gentle products to the brand allows us to provide acomplete range of foam dressings to our customers, ensuring our continuedsuccess in this segment of the market. These two new products will add a newlevel of versatility and breadth of application to the ALLEVYN range to supportour customers in providing the best possible patient care." ALLEVYN Gentle Border is a silicone gel adhesive hydrocellular foam dressing,designed to minimise pain to the patient and trauma to the wound at dressingchange with longer wear time for patients with fragile skin; ALLEVYN Gentle is asoft-gel adhesive hydrocellular foam dressing designed to facilitate easierapplication when secondary retention is required and minimises pain on removalfor patients with fragile skin. "The new ALLEVYN range will further enhance the care that HealthcareProfessionals can provide to patients with problematic wounds. The ALLEVYNGentle and Gentle Border variants should help overcome the challenges inminimising pain for patients with fragile skin including patients with fragilehealing burn wounds," said Simon Booth, Burn Researcher, Queen VictoriaHospital, East Grinstead. Enquiries Sidonie Myers Tel: +44 (0) 1482 673246Head of CommunicationSmith & Nephew Advanced Wound Management Notes for Editors About ALLEVYN The ALLEVYN product range helps to facilitate healing by reducing the risk ofmaceration (softening and whitening of the skin that increases the risk ofinfection) and maintaining an optimal moist wound environment. ALLEVYN offersthe clinician a clinically proven range of dressings that are cost effectiveboth for the clinician and the buyer. With the addition of ALLEVYN Gentle andALLEVYN Gentle Border to the range, ALLEVYN now expands a clinician's capacityto minimise pain, maximise patient comfort and optimise healing for morepatients in more situations. ALLEVYN now further simplifies customer choice, by providing a new, unique andpowerful combination of benefits through each of the four product groups in itsnewly defined and extended range. ALLEVYN has now combined the proven strengthsof its triple-action ALLEVYN technology with a new level of versatility andbreadth of application. The three new products in the range are: ALLEVYN Ag - All the benefits of ALLEVYN, with the addition of anti-microbialsilver for use on wounds with suspected infection or infected wounds treated asper local protocol. ALLEVYN Gentle Border - All the benefits of ALLEVYN with the addition of asilicone gel adhesive for use on patients with fragile skin where secondaryretention is not used. ALLEVYN Gentle - All the benefits of ALLEVYN with the addition of a soft geladhesive for use on patients with fragile skin when secondary retention isrequired. About Smith & Nephew Smith & Nephew Advanced Wound Management is headquartered in the United Kingdom.The organisation has manufacturing centres in the United Kingdom and Largo, FL. Smith & Nephew is a global medical technology business, specialising inOrthopaedic Reconstruction, Orthopaedic Trauma and Clinical Therapies, Endoscopyand Advanced Wound Management products. Smith & Nephew is a global leader inarthroscopy and advanced wound management and is one of the leading globalorthopaedics companies. Smith & Nephew is dedicated to helping improve people's lives. The Companyprides itself on the strength of its relationships with its surgeons andprofessional healthcare customers, with whom its name is synonymous with highstandards of performance, innovation and trust. The Company operates in 32countries around the world. Annual sales in 2006 were nearly $2.8 billion. Forward-Looking Statements This press release contains certain "forward-looking statements" within themeaning of the US Private Securities Litigation Reform Act of 1995. In particular, statements regardingexpected revenue growth and trading margins discussed under "Outlook" areforward-looking statements as are discussions of our product pipeline. Thesestatements, as well as the phrases "aim", "plan", "intend", "anticipate","well-placed", "believe", "estimate", "expect", "target", "consider" and similarexpressions, are generally intended to identify forward-looking statements. Suchforward-looking statements involve known and unknown risks, uncertainties andother important factors (including, but not limited to, the outcome oflitigation, claims and regulatory approvals) that could cause the actualresults, performance or achievements of Smith & Nephew, or industry results, todiffer materially from any future results, performance or achievements expressedor implied by such forward-looking statements. Please refer to the documentsthat Smith & Nephew has filed with the U.S. Securities and Exchange Commissionunder the U.S. Securities Exchange Act of 1934, as amended, including Smith &Nephew's most recent annual report on Form 20F, for a discussion of certain ofthese factors. All forward-looking statements in this press release are based on informationavailable to Smith & Nephew as of the date hereof. All written or oralforward-looking statements attributable to Smith & Nephew or any person actingon behalf of Smith & Nephew are expressly qualified in their entirety by theforegoing. Smith & Nephew does not undertake any obligation to update or reviseany forward-looking statement contained herein to reflect any change in Smith &Nephew's expectation with regard thereto or any change in events, conditions orcircumstances on which any such statement is based. * Trademark of Smith & Nephew. Certain marks registered US Patent and TrademarkOffice. ### This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Smith & Nephew